https://www.england.nhs.uk/national-emergency-pressures-panel-nepp/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4095", "label" : {"_value" : "Biography information for Steve Barclay"}
}
, "answeringMemberConstituency" : {"_value" : "North East Cambridgeshire"}
, "answeringMemberPrinted" : {"_value" : "Stephen Barclay"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T17:44:58.223Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "National Emergency Pressures Panel"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many times the national emergency pressures panel has met during the 2018-19 financial year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4426", "label" : {"_value" : "Biography information for Paula Sherriff"}
}
, "tablingMemberConstituency" : {"_value" : "Dewsbury"}
, "tablingMemberPrinted" : [{"_value" : "Paula Sherriff"}
], "uin" : "184974"}
, {"_about" : "http://data.parliament.uk/resources/997151", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997151/answer", "answerText" : {"_value" : "There are two Clinical Commissioning Group Improvement and Assessment Framework (CCG IAF) indicators on which CCGs are given a Red, Amber or Green rating. Ratings are combined to give an overall diabetes rating for individual CCGs. The indicators are as follows:<\/p>
- Diabetes patients that have achieved all the National Institute for Health and Care Excellence (NICE) recommended treatment targets: three (HbA1c, cholesterol and blood pressure) for adults and one (HbA1c) for children; and<\/p>
- People with diabetes diagnosed less than a year ago who attend a structured education course.<\/p>
<\/p>
The overall diabetes rating for Coventry and Rugby CCG in the most recent 2016/17 assessment was \u2018Requires Improvement\u2019, following a Green rating for patients achieving all the NICE recommended treatment targets and a Red rating for attendances at structured education courses.<\/p>
<\/p>
CCGs across England received the following overall ratings in relation to diabetes:<\/p>
- Outstanding - 40 CCGs;<\/p>
- Good - 46 CCGs;<\/p>
- Requires Improvement - 102 CCGs; and<\/p>
- Inadequate - 19 CCGs.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T17:00:53.497Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Diabetes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the quality of care provision for people with diabetes in (a) NHS Coventry and Rugby Clinical Commissioning Group and (b) England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"}
], "uin" : "184864"}
, {"_about" : "http://data.parliament.uk/resources/997153", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997153/answer", "answerText" : {"_value" : "
The Department has no current plans to review or amend the list of medical conditions that provide exemption from prescription charges because arrangements exist to ensure that prescriptions are affordable for everyone. Accordingly, no recent discussions about this matter have taken place at Ministerial level with NHS England.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T16:57:25.33Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prescriptions: Fees and Charges"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS England on the list of medical conditions that entitle people to medical exemption certificates; and whether he plans to include additional medical conditions on that list.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/308", "label" : {"_value" : "Biography information for Mr Jim Cunningham"}
}
, "tablingMemberConstituency" : {"_value" : "Coventry South"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jim Cunningham"}
], "uin" : "184866"}
, {"_about" : "http://data.parliament.uk/resources/997156", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997156/answer", "answerText" : {"_value" : "
As part of the delivery of essential medical services under the General Medical Services Contract Regulations, general practitioner practices must offer consultation and, where appropriate, physical examination for the purposes of identifying the need, if any, for treatment or further investigation. Practices should carry out treatment or further investigation as is necessary and appropriate, including the referral of a patient to other services or other health care professionals.<\/p>
<\/p>
Patients aged over 25 are, of course, eligible for the cervical screening programme.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T16:54:14.2Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cervical Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether GP\u2019s have authority to request cervical cancer smear tests when patients under 25 show symptoms of cervical cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4506", "label" : {"_value" : "Biography information for Antoinette Sandbach"}
}
, "tablingMemberConstituency" : {"_value" : "Eddisbury"}
, "tablingMemberPrinted" : [{"_value" : "Antoinette Sandbach"}
], "uin" : "184977"}
, {"_about" : "http://data.parliament.uk/resources/997164", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997164/answer", "answerText" : {"_value" : "
NHS England is working with the manufacturers and National Health Service providers to prepare the NHS to begin delivering Chimeric Antigen Receptor T Cell (CAR-T) therapy - the first in a wave of treatments in a new era of personalised medicine and part of the NHS\u2019s long-term plan to upgrade cancer service. The first treatment that will be available to patient is tisagenlecleucel (Kymriah) as an option for treating children and young people up to 25 years old with B cell acute lymphoblastic leukaemia that is refractory, in relapsed post-transplant or in second or later relapse.<\/p>
<\/p>
NHS England anticipates that the National Institute for Health and Care Excellence will recommend this treatment for entry into the Cancer Drugs Fund in mid-November. If so, funding will be made immediately available, following a successful commercial deal with the manufacturer Novartis. We anticipate the first patients will begin their treatment in late November 2018. The phased implementation required by the manufacturer and the NHS means that full capacity to treat eligible patients will take some months to achieve and a National CAR-T Clinical Panel will convene in mid-November to assure equity of access and prioritise eligible patients.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "184985"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T16:55:17.567Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, on what date CAR-T therapy for adult cancer patients will be made available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4249", "label" : {"_value" : "Biography information for Anne Marie Morris"}
}
, "tablingMemberConstituency" : {"_value" : "Newton Abbot"}
, "tablingMemberPrinted" : [{"_value" : "Anne Marie Morris"}
], "uin" : "184984"}
, {"_about" : "http://data.parliament.uk/resources/997165", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997165/answer", "answerText" : {"_value" : "
NHS England is working with the manufacturers and National Health Service providers to prepare the NHS to begin delivering Chimeric Antigen Receptor T Cell (CAR-T) therapy - the first in a wave of treatments in a new era of personalised medicine and part of the NHS\u2019s long-term plan to upgrade cancer service. The first treatment that will be available to patient is tisagenlecleucel (Kymriah) as an option for treating children and young people up to 25 years old with B cell acute lymphoblastic leukaemia that is refractory, in relapsed post-transplant or in second or later relapse.<\/p>
<\/p>
NHS England anticipates that the National Institute for Health and Care Excellence will recommend this treatment for entry into the Cancer Drugs Fund in mid-November. If so, funding will be made immediately available, following a successful commercial deal with the manufacturer Novartis. We anticipate the first patients will begin their treatment in late November 2018. The phased implementation required by the manufacturer and the NHS means that full capacity to treat eligible patients will take some months to achieve and a National CAR-T Clinical Panel will convene in mid-November to assure equity of access and prioritise eligible patients.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "184984"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T16:55:17.647Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when CAR-T therapy for adult cancer patients will be made available for patients in Torbay and Plymouth hospitals.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4249", "label" : {"_value" : "Biography information for Anne Marie Morris"}
}
, "tablingMemberConstituency" : {"_value" : "Newton Abbot"}
, "tablingMemberPrinted" : [{"_value" : "Anne Marie Morris"}
], "uin" : "184985"}
, {"_about" : "http://data.parliament.uk/resources/997196", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997196/answer", "answerText" : {"_value" : "
Tables showing the number of people who were diagnosed with type 2 or other diabetes in each of the five calendar years 2012 to 2016 in each clinical commissioning group, by ten-year age band, and the number of people who were diagnosed with type 2 or other diabetes in each of the five calendar years 2012 to 2016 in each clinical commissioning group, by gender are attached.<\/p>
<\/p>
Disclosure control has been applied to all figures, as per the National Diabetes Audit publication. All numbers are rounded to the nearest five, unless the number is one to seven, in which case it is rounded to \u2018five\u2019.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/997196/answer/attachment/1", "fileName" : {"_value" : "DATAPQ184908.xlsx"}
, "title" : "PQ184908 attached data"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T16:32:37.347Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Diabetes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people have been diagnosed with type two diabetes by (a) age and (b) gender in each clinical commissioning group area in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1463", "label" : {"_value" : "Biography information for Lord Watson of Wyre Forest"}
}
, "tablingMemberConstituency" : {"_value" : "West Bromwich East"}
, "tablingMemberPrinted" : [{"_value" : "Tom Watson"}
], "uin" : "184908"}
, {"_about" : "http://data.parliament.uk/resources/997248", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997248/answer", "answerText" : {"_value" : "
Clinical commissioning groups (CCGs) should have regard to the National Institute for Health and Care Excellence (NICE) guideline on the assessment and treatment of people with fertility problems when commissioning services for which they are responsible. This includes the recommendation in the guideline that three cycles of in-vitro fertilisation be offered to qualifying couples where the woman is under the age of 40 and one cycle where the woman is between the ages of 40 and 42.<\/p>
<\/p>
The NICE guideline is evidence based best practice for clinicians but is not mandatory. The availability of National Health Service funded fertility treatment is matter for local determination. Decisions on the level of service provision are underpinned by clinical insight and knowledge of local healthcare needs and priorities.<\/p>
<\/p>
Information about the commissioning of fertility services is not collected centrally but an annual survey is undertaken by Fertility Fairness. This can be found at the following link:<\/p>
<\/p>
http://www.fertilityfairness.co.uk/wp-content/uploads/2018/10/England-FertilityFairness_FOI_2018.pdf<\/a><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-01T16:52:39.78Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "IVF"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that Clinical Commissioning Groups meet guidelines that IVF should be offered to women until age 42; what estimate he has made of the number of Clinical Commissioning Groups that do not meet these guidelines; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4656", "label" : {"_value" : "Biography information for Layla Moran"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "tablingMemberPrinted" : [{"_value" : "Layla Moran"}
], "uin" : "185122"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answeringDeptId=17&min-answer.questionFirstAnswered.=2014-11-17T11%3A15%3A33.017Z&max-answer.questionFirstAnswered.=2018-11-02T13%3A36%3A14.267Z", "page" : 0, "startIndex" : 1, "totalResults" : 27002, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}